- Management of psoriatic disease with anti IL-17 and anti-IL-23 monoclonal antibodies2022 | Faculty of Medicine in Hradec Králové
- Paradoxical Reactions to Anti-TNFα and Anti-IL-17 Treatment in Psoriasis Patients: Are Skin and/or Gut Microbiota Involved?2023 | Second Faculty of Medicine
- Current Approach to Modern Treatment of Psoriasis - Updated Guidelines of ČDS JEP for Targeted Treatment of Severe Chronic Psoriasis2019 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Third Faculty of Medicine
- Invasive aspergillus infection of middle ear in a patient treated with secukinumab, methotrexate and corticosteroids for psoriasis and psoriatic arthritis2022 | Second Faculty of Medicine, Faculty of Medicine in Hradec Králové
- Efficacy of biological treatment of moderate to severe psoriasis - analysis from the BIOREP Registry2021 | Faculty of Medicine in Pilsen, First Faculty of Medicine, Third Faculty of Medicine, Central Library of Charles University
- Psoriasis treatment goals - time for a change?2023 | Faculty of Medicine in Pilsen
- Prevalence of genital and oral human papillomavirus infection among psoriasis patients on biologic therapy2022 | Third Faculty of Medicine, Second Faculty of Medicine, Faculty of Science
- Crohn’s disease in a young psoriatic patient previously exposed to ixekizumab2021 | Second Faculty of Medicine